Select Medical’s (SEM) Buy Rating Reiterated at Benchmark

Select Medical (NYSE:SEM)‘s stock had its “buy” rating restated by equities research analysts at Benchmark in a note issued to investors on Friday, Benzinga reports. They presently have a $48.00 price objective on the health services provider’s stock. Benchmark’s target price would indicate a potential upside of 32.38% from the company’s previous close.

Separately, Bank of America initiated coverage on shares of Select Medical in a research note on Tuesday, August 20th. They set a “buy” rating and a $42.00 price objective on the stock. One investment analyst has rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $39.00.

Select Medical Price Performance

Shares of NYSE:SEM traded up $4.18 on Friday, reaching $36.26. 436,168 shares of the company were exchanged, compared to its average volume of 597,072. The company has a current ratio of 1.09, a quick ratio of 1.09 and a debt-to-equity ratio of 2.11. The firm has a market cap of $4.71 billion, a price-to-earnings ratio of 17.38, a price-to-earnings-growth ratio of 2.03 and a beta of 1.41. Select Medical has a 1-year low of $21.28 and a 1-year high of $40.50. The company has a 50-day moving average of $34.25 and a 200-day moving average of $33.91.

Select Medical (NYSE:SEM) last posted its earnings results on Thursday, August 1st. The health services provider reported $0.60 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.61 by ($0.01). The business had revenue of $1.76 billion for the quarter, compared to analyst estimates of $1.74 billion. Select Medical had a return on equity of 17.50% and a net margin of 3.91%. The firm’s revenue for the quarter was up 5.1% compared to the same quarter last year. During the same period last year, the company posted $0.61 EPS. Equities analysts forecast that Select Medical will post 2.03 earnings per share for the current fiscal year.

Institutional Trading of Select Medical

A number of hedge funds and other institutional investors have recently made changes to their positions in SEM. Allspring Global Investments Holdings LLC increased its position in shares of Select Medical by 6.6% in the 1st quarter. Allspring Global Investments Holdings LLC now owns 6,563 shares of the health services provider’s stock worth $198,000 after purchasing an additional 405 shares during the last quarter. BNP Paribas Financial Markets grew its position in shares of Select Medical by 26.1% in the 1st quarter. BNP Paribas Financial Markets now owns 55,543 shares of the health services provider’s stock worth $1,675,000 after acquiring an additional 11,507 shares in the last quarter. Capstone Investment Advisors LLC bought a new position in Select Medical in the first quarter worth about $690,000. Fidelis Capital Partners LLC bought a new position in shares of Select Medical during the first quarter valued at approximately $47,000. Finally, Essex Investment Management Co. LLC increased its holdings in shares of Select Medical by 16.9% in the 1st quarter. Essex Investment Management Co. LLC now owns 156,574 shares of the health services provider’s stock worth $4,721,000 after acquiring an additional 22,674 shares during the period. Institutional investors own 89.48% of the company’s stock.

About Select Medical

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.